Gilead Sciences (GILD) Interest Expenses (2009 - 2026)

Gilead Sciences has reported Interest Expenses for 18 years, with the latest figure at $240.0 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses fell 7.69% year-over-year to $240.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (up 2.13% YoY), and the FY2025 full-year result was $1.0 billion, up 4.81% from the prior year.
• Interest Expenses for Q1 2026 stood at $240.0 million, down from $255.0 million in the prior quarter.
• The five-year high for Interest Expenses was $260.0 million in Q1 2025, with the low at $226.0 million in Q4 2022.
• Historically, Interest Expenses has averaged $242.5 million across 5 years, with a median of $240.0 million in 2026.
• Annual changes were most pronounced in 2022 — Interest Expenses slipped 8.4% — and 2023, when it climbed 11.5%.
• Gilead Sciences' Interest Expenses stood at $226.0 million in 2022, then climbed by 11.5% to $252.0 million in 2023, then slipped by 1.19% to $249.0 million in 2024, then increased by 2.41% to $255.0 million in 2025, then slipped by 5.88% to $240.0 million in 2026.
• The last three Interest Expenses figures came in at $240.0 million (Q1 2026), $255.0 million (Q4 2025), and $256.0 million (Q3 2025), per Business Quant data.